Edition:
United States

Boiron SA (BOIR.PA)

BOIR.PA on Paris Stock Exchange

81.40EUR
21 Apr 2017
Change (% chg)

€-1.84 (-2.21%)
Prev Close
€83.24
Open
€83.24
Day's High
€83.24
Day's Low
€80.12
Volume
13,238
Avg. Vol
5,900
52-wk High
€92.91
52-wk Low
€66.10

BOIR.PA

Chart for BOIR.PA

About

Boiron SA is a France-based pharmaceutical company engaged in the provision of homeopathic medicines. The Company develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. It also produces medicines based on trace elements, phytotherapy... (more)

Overall

Beta: 1.00
Market Cap(Mil.): €1,580.36
Shares Outstanding(Mil.): 19.41
Dividend: 1.60
Yield (%): 1.97

Financials

  BOIR.PA Industry Sector
P/E (TTM): 19.30 29.08 29.95
EPS (TTM): 4.22 -- --
ROI: 13.64 13.66 13.21
ROE: 17.56 14.61 14.38

BRIEF-Boiron Q1 revenue up at 160.3 mln euros

* Q1 revenue 160.3 million euros ($172.1 million) versus 154.1 million euros year ago

Apr 20 2017

BRIEF-Boiron FY net income group share rises to 77.7 million euros

* FY revenue 614.5 million euros ($653.52 million) versus 607.8 million euros year ago

Mar 15 2017

BRIEF-Boiron announces acquisition of Laboratoire Ferrier

* Laboratoires Boiron and Laboratoires Arkopharma signed an agreement for the takeover on 1st of March 2017 by Boiron of Laboratoire Ferrier, a subsidiary of Arkopharma

Feb 08 2017

BRIEF-Boiron FY revenue up at 614.5 million euros

* FY revenue 614.5 million euros ($655.73 million) versus 607.8 million euros year ago

Jan 26 2017

More From Around the Web

Earnings vs. Estimates